Point72 Asset Management, L.P. - LIGAND PHARMACEUTICALS INC ownership

LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 210 filers reported holding LIGAND PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.15 and the average weighting 0.1%.

Quarter-by-quarter ownership
Point72 Asset Management, L.P. ownership history of LIGAND PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2023$5,983
-97.7%
81
-97.2%
0.00%
-100.0%
Q2 2022$259,000
-97.3%
2,900
-96.6%
0.00%
-97.4%
Q1 2022$9,618,000
+15.1%
85,500
+58.0%
0.04%
+15.2%
Q4 2021$8,356,000
+3768.5%
54,100
+2284.3%
0.03%
+3200.0%
Q3 2020$216,000
-92.1%
2,269
-77.3%
0.00%
-90.9%
Q3 2018$2,745,00010,0000.01%
Other shareholders
LIGAND PHARMACEUTICALS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Knott David M Jr 115,000$8,4593.32%
VILLERE ST DENIS J & CO LLC 480,807$35,368,1622.57%
Chicago Capital, LLC 449,508$33,065,8221.64%
RICE HALL JAMES & ASSOCIATES, LLC 288,345$21,210,6811.20%
Smith, Graham & Co., Investment Advisors, LP 65,163$4,793,3900.58%
Stephens Investment Management Group LLC 455,089$33,476,3470.56%
CARDINAL CAPITAL MANAGEMENT LLC /CT 201,993$14,858,6050.53%
WOODSTOCK CORP 52,604$3,869,5500.49%
Court Place Advisors, LLC 15,533$1,142,6070.41%
Jackson Creek Investment Advisors LLC 12,726$9360.39%
View complete list of LIGAND PHARMACEUTICALS INC shareholders